Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis
Abstract Background The detection rate of Barcelona Clinic Liver Cancer (BCLC) very-early-stage hepatocellular carcinoma (HCC) is increasing because of advances in surveillance and improved imaging technologies for high-risk populations. Surgical resection (SR) and radiofrequency ablation (RFA) are...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/850c695ce76e4112bcd27dda36583dd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:850c695ce76e4112bcd27dda36583dd1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:850c695ce76e4112bcd27dda36583dd12021-11-14T12:16:52ZClinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis10.1186/s12876-021-01995-z1471-230Xhttps://doaj.org/article/850c695ce76e4112bcd27dda36583dd12021-11-01T00:00:00Zhttps://doi.org/10.1186/s12876-021-01995-zhttps://doaj.org/toc/1471-230XAbstract Background The detection rate of Barcelona Clinic Liver Cancer (BCLC) very-early-stage hepatocellular carcinoma (HCC) is increasing because of advances in surveillance and improved imaging technologies for high-risk populations. Surgical resection (SR) and radiofrequency ablation (RFA) are both first‐line treatments for very-early-stage HCC, but the differences in clinical outcomes between patients treated with SR and RFA remain unclear. This study investigated the prognosis of SR and RFA for very-early‐stage HCC patients with long‐term follow‐up. Methods This study was retrospectively collected data on the clinicopathological characteristics, overall survival (OS), and disease-free survival (DFS) of 188 very-early-stage HCC patients (≤ 2 cm single HCC). OS and DFS were analyzed using the Kaplan–Meier method and Cox regression analysis. Propensity score matching (PSM) analysis was performed. Results Of the 188 HCC patients, 103 received SR and 85 received RFA. The median follow‐up time was 56 months. The SR group had significantly higher OS than the RFA group (10-year cumulative OS: 55.2% and 31.3% in the SR and RFA groups, respectively). No statistically significant difference was observed in DFS between the SR and RFA groups (10-year cumulative DFS: 45.9% and 32.6% in the SR and RFA groups, respectively). After PSM, the OS in the SR group remained significantly higher than that in the RFA group (10-year cumulative OS: 54.7% and 42.2% in the SR and RFA groups, respectively). No significant difference was observed in DFS between the SR and RFA groups (10-year cumulative DFS: 43.0% and 35.4% in the SR and RFA groups, respectively). Furthermore, in the multivariate Cox regression analysis, treatment type (hazard ratio (HR): 0.54, 95% confidence interval (CI): 0.31–0.95; P = 0.032) and total bilirubin (HR: 1.92; 95% CI: 1.09–3.41; P = 0.025) were highly associated with OS. In addition, age (HR: 2.14, 95% CI: 1.36–3.36; P = 0.001) and cirrhosis (HR: 1.79; 95% CI: 1.11–2.89; P = 0.018) were strongly associated with DFS. Conclusion For patients with very-early-stage HCC, SR was associated with significantly higher OS rates than RFA. However, no significant difference was observed in DFS between the SR and RFA groups.Yuan-Chen LiPing-Hung ChenJen-Hao YehPojen HsiaoGin-Ho LoTaoQian TanPin-Nan ChengHung-Yu LinYaw-Sen ChenKun-Chou HsiehPei-Min HsiehChih-Wen LinBMCarticleSurgical proceduresRadiofrequency ablationVery-early-stage hepatocellular carcinomaOverall survivalDisease-free survivalDiseases of the digestive system. GastroenterologyRC799-869ENBMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Surgical procedures Radiofrequency ablation Very-early-stage hepatocellular carcinoma Overall survival Disease-free survival Diseases of the digestive system. Gastroenterology RC799-869 |
spellingShingle |
Surgical procedures Radiofrequency ablation Very-early-stage hepatocellular carcinoma Overall survival Disease-free survival Diseases of the digestive system. Gastroenterology RC799-869 Yuan-Chen Li Ping-Hung Chen Jen-Hao Yeh Pojen Hsiao Gin-Ho Lo TaoQian Tan Pin-Nan Cheng Hung-Yu Lin Yaw-Sen Chen Kun-Chou Hsieh Pei-Min Hsieh Chih-Wen Lin Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
description |
Abstract Background The detection rate of Barcelona Clinic Liver Cancer (BCLC) very-early-stage hepatocellular carcinoma (HCC) is increasing because of advances in surveillance and improved imaging technologies for high-risk populations. Surgical resection (SR) and radiofrequency ablation (RFA) are both first‐line treatments for very-early-stage HCC, but the differences in clinical outcomes between patients treated with SR and RFA remain unclear. This study investigated the prognosis of SR and RFA for very-early‐stage HCC patients with long‐term follow‐up. Methods This study was retrospectively collected data on the clinicopathological characteristics, overall survival (OS), and disease-free survival (DFS) of 188 very-early-stage HCC patients (≤ 2 cm single HCC). OS and DFS were analyzed using the Kaplan–Meier method and Cox regression analysis. Propensity score matching (PSM) analysis was performed. Results Of the 188 HCC patients, 103 received SR and 85 received RFA. The median follow‐up time was 56 months. The SR group had significantly higher OS than the RFA group (10-year cumulative OS: 55.2% and 31.3% in the SR and RFA groups, respectively). No statistically significant difference was observed in DFS between the SR and RFA groups (10-year cumulative DFS: 45.9% and 32.6% in the SR and RFA groups, respectively). After PSM, the OS in the SR group remained significantly higher than that in the RFA group (10-year cumulative OS: 54.7% and 42.2% in the SR and RFA groups, respectively). No significant difference was observed in DFS between the SR and RFA groups (10-year cumulative DFS: 43.0% and 35.4% in the SR and RFA groups, respectively). Furthermore, in the multivariate Cox regression analysis, treatment type (hazard ratio (HR): 0.54, 95% confidence interval (CI): 0.31–0.95; P = 0.032) and total bilirubin (HR: 1.92; 95% CI: 1.09–3.41; P = 0.025) were highly associated with OS. In addition, age (HR: 2.14, 95% CI: 1.36–3.36; P = 0.001) and cirrhosis (HR: 1.79; 95% CI: 1.11–2.89; P = 0.018) were strongly associated with DFS. Conclusion For patients with very-early-stage HCC, SR was associated with significantly higher OS rates than RFA. However, no significant difference was observed in DFS between the SR and RFA groups. |
format |
article |
author |
Yuan-Chen Li Ping-Hung Chen Jen-Hao Yeh Pojen Hsiao Gin-Ho Lo TaoQian Tan Pin-Nan Cheng Hung-Yu Lin Yaw-Sen Chen Kun-Chou Hsieh Pei-Min Hsieh Chih-Wen Lin |
author_facet |
Yuan-Chen Li Ping-Hung Chen Jen-Hao Yeh Pojen Hsiao Gin-Ho Lo TaoQian Tan Pin-Nan Cheng Hung-Yu Lin Yaw-Sen Chen Kun-Chou Hsieh Pei-Min Hsieh Chih-Wen Lin |
author_sort |
Yuan-Chen Li |
title |
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
title_short |
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
title_full |
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
title_fullStr |
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
title_full_unstemmed |
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
title_sort |
clinical outcomes of surgical resection versus radiofrequency ablation in very-early‐stage hepatocellular carcinoma: a propensity score matching analysis |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/850c695ce76e4112bcd27dda36583dd1 |
work_keys_str_mv |
AT yuanchenli clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT pinghungchen clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT jenhaoyeh clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT pojenhsiao clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT ginholo clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT taoqiantan clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT pinnancheng clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT hungyulin clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT yawsenchen clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT kunchouhsieh clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT peiminhsieh clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis AT chihwenlin clinicaloutcomesofsurgicalresectionversusradiofrequencyablationinveryearlystagehepatocellularcarcinomaapropensityscorematchinganalysis |
_version_ |
1718429298168168448 |